Exemptions granted for limited sale and supply without prescription (with effect from 1 Dec 2016):
As an intranasal spray not exceeding 50 mcg/actuation
Indication: Prevention and treatment of allergic rhinitis
Maximum daily dose: 200 mcg
Maximum supply: 3 months
Minimum age: 18 years